Albers Jeffrey W.

Related Filers (4)

Other (4)

144
Thursday, 1/25/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 1/23/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 11/24/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 8/24/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (72)

4
Tuesday, 1/23/2024
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
3/A
Friday, 12/8/2023
Spyre Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4/A
Friday, 12/8/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/4/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/28/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
3
Monday, 11/27/2023
Spyre Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/27/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/3/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 9/29/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Monday, 8/28/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/8/2023
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/7/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/23/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 8/18/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/10/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 6/30/2022
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/18/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 4/8/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/8/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/17/2021
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/3/2021
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Monday, 8/30/2021
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Monday, 8/23/2021
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 6/17/2021
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/3/2021
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/14/2021
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 3/5/2021
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/3/2021
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/16/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/18/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 10/9/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 8/21/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 8/21/2020
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/20/2020
Kymera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/9/2020
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/14/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/25/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/11/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/3/2020
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/20/2019
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/30/2019
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/21/2019
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/19/2019
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 6/14/2019
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/11/2019
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/19/2019
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/5/2019
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/21/2018
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/7/2018
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/27/2018
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/20/2018
Magenta Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 5/9/2018
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/6/2018
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/20/2018
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/8/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/9/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 6/30/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 3/16/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2017
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/10/2016
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/7/2016
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 4/8/2016
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Friday, 2/5/2016
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 11/12/2015
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/4/2015
Blueprint Medicines Corp: Statement of changes in beneficial ownership of securities
3
Thursday, 4/30/2015
Blueprint Medicines Corp: Initial statement of beneficial ownership of securities
Show More